BLPH — Bellerophon Therapeutics Share News
0.000.00%
Last trade - 00:00Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen
U.S. STOCKS ON THE MOVE-Verizon Communications, Danaher, General Electric
Bellerophon Therapeutics plunges on delisting notice from Nasdaq
Brief: Bellerophon Therapeutics Inc Got Notice Of Delisting From Nasdaq
Brief: Bellerophon Therapeutics Says On June 24, Board Approved Reduction-In-Force Of Substantially All Of Co’S Employees,Including Executive Officers
U.S. STOCKS ON THE MOVE-Spotify, Akero Therapeutics, Cyxtera Technologies
U.S. STOCKS ON THE MOVE-Tesla, Moderna, Oil tanker firms
Bellerophon plunges as lung disease treatment fails in late-stage study
U.S. STOCKS ON THE MOVE-Foghorn Therapeutics, Novavax, Apple
Bellerophon plunges as lung disease treatment fails in late-stage study
Brief: Bellerophon Announces Top-Line Data From Phase 3 Rebuild Clinical Trial Of INOpulse
Brief: Bellerophon Therapeutics Inc Files For Mixed Shelf Of Up To $150 Million - SEC Filing
Brief: Bellerophon Provides Clinical Program Update And Reports First Quarter 2023 Financial Results
Bellerophon Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Bellerophon Therapeutics Inc Principal Financial And Accounting Officer Notifies Intent To Resign
Bellerophon Therapeutics Inc reports results for the quarter ended in December - Earnings Summary